Low Dose Dexmedetomidine as a Postoperative Pain Adjunct

Part of paid clinical trials in Kansas City, Missouri.

Sponsor
Nichole Doyle
Study ID
NCT06067893
Phase
PHASE4
Status
Enrolling By Invitation

Conditions

  • Adolescent Idiopathic Scoliosis
  • Spinal Fusion

Eligibility Criteria

Sex
ALL
Age
10 Years - 21 Years
Healthy Volunteers
Accepted

Interventions

  • Dexmedetomidine — DRUG
    Patient receives dexmedetomidine for 48 hours post-operatively
  • Normal Saline — DRUG
    Patient receives normal saline for 48 hours post-operatively

Study Details

This randomized controlled trial examines whether the addition of a low-dose dexmedetomidine infusion to our current multimodal pain management plan decreases narcotic consumption and reduces side effects in adolescent patients undergoing posterior spinal fusion for idiopathic scoliosis.

Key Dates

Start date
Jul 1, 2024
Status verified
Dec 2025
Primary completion
Jul 31, 2026
Completion
Jul 31, 2026

Study Design

Enrollment
160 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Dexmedetomidine
    Patient receives low dose dexmedetomidine infusion in addition to normal post-operative pain management protocol
  • Placebo Comparator: Control
    Patient receives normal saline infusion in addition to normal post-operative pain management protocol

Primary Outcome Measure

narcotic consumption [ Time Frame: 48 hours post-operatively ]

Locations (1)

FacilityCityStateZIPSite coordinators
Children's Mercy HospitalKansas CityMissouri64108-

Find similar trials in Kansas City, MO

By research site
Children's Mercy Hospital· Kansas City, MO

Related Studies